Brevan Howard Capital Management LP Silk Road Medical Inc Transaction History

Brevan Howard Capital Management LP

  • $14.2 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$16.95 - $27.04 $114,327 - $182,384
-6,745 Reduced 22.4%
23,362 $631,000
Q1 2024

May 15, 2024
BUY
$11.38 - $19.03 $135,091 - $225,905
11,871 Added 65.1%
30,107 $551,000
Q4 2023

Feb 14, 2024
BUY
$6.29 - $15.72 $114,704 - $286,669
18,236 New
18,236 $223,000

Others Institutions Holding SILK

# of Institutions
5
Shares Held
3.48M
Call Options Held
19.8K
Put Options Held
0
View Full List

About Silk Road Medical Inc

SILK Quotes by TradingView
  • Ticker SILK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,565,600
  • Market Cap $1.03B
  • Description
  • Silk Road Medical, Inc. operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization. Its products include ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and initiate te...
More about SILK
Track This Portfolio

Track Brevan Howard Capital Management LP Portfolio

Follow Brevan Howard Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brevan Howard Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Brevan Howard Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email